⚕ GalenOps CRO console
← 711 (USA)

711-1012

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 711 (USA) (Dr. Jansen) · consented 2013-04-03
Adverse events
7
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-16 (study day 14.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-16 (study day 14.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-16 (study day 14.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-16 (study day 14.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-04-16 (study day 14.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE URTICARIA — outcome: RECOVERED/RESOLVED; onset 2013-04-29 (study day 27.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate NASOPHARYNGITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-27 (study day 25.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.